Barriers to cancer pain management with opioids: Patientrelated barriers to cancer pain management and health care professional,Used

Barriers to cancer pain management with opioids: Patientrelated barriers to cancer pain management and health care professional,Used

In Stock
SKU: DADAX3838358902
Brand: LAP Lambert Academic Publishing
$75.42 $107.74
Save $32.32
Quantity
Add to wishlist
Add to compare

Processing time: 1-3 days

US Orders Ships in: 3-5 days

International Orders Ships in: 8-12 days

Return Policy: 15-days return on defective items

Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

The aims of the project were to analyze patientrelated barriers to cancer pain management and to describe clinical rationale for the choice of administration form with fentanyl. To answer the research questions related to the first aim, a questionnaire survey among cancer patients from the Danish pain centres and pain clinics was conducted. Survey results showed that a psychoemotional status of patients significantly explained pain intensity, while patients' attitudes towards the importance of pain management with opioids significantly explained pain relief. Thus, interventions in cancer patients' emotional distress and concerns could result in better pain management outcomes. To answer research questions related to the second aim, two Delphi surveys were conducted, among Danish pain specialists and pain nurses, respectively. The results of these studies showed the expectations regarding the use of Fentanylpatches were met, however, expectations concerning the use of Fentanyl lollipops were not met in terms of comfort and usability of this administration form for terminal pain patients.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed